Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

ImmuCell's TravelGAM to enter field study in cooperation with U.S. Navy

April 24, 1997

DA-9601 shows promise for IBD

April 23, 1997

Isis Pharmaceuticals initiates phase III trials of its antisense drug for Crohn's disease

April 22, 1997

Cholecystokinin antagonists for pancreatic disorders described by Tanabe

April 18, 1997

New antiulcer agents from Fujisawa

April 17, 1997

Eisai/Janssen form strategic alliance for rabeprazole

April 17, 1997

Antiulcer activity of cromakalim

April 17, 1997

Mechanism of HCV resistance to interferon discovered

April 16, 1997

Milestone reached in Genome Therapeutics/Astra H. pylori collaboration

April 11, 1997

Encouraging phase III results reported for lamivudine as hepatitis B treatment

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...